520A — J-Pharma Co Balance Sheet
0.000.00%
Last trade - 00:00Annual balance sheet for J-Pharma Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2024 March 31st | 2025 March 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | JAS | JAS |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Cash and Short Term Investments | 1,073 | 2,302 |
| Net Total Receivables | 23.9 | 16.2 |
| Prepaid Expenses | ||
| Total Other Current Assets | ||
| Total Current Assets | 1,190 | 2,839 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 0 | 0 |
| Net Intangible Assets | ||
| Long Term Investments | ||
| Other Long Term Assets | ||
| Total Assets | 1,207 | 2,857 |
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 200 | 452 |
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 257 | 479 |
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Other Equity | ||
| Total Equity | 950 | 2,378 |
| Total Liabilities & Shareholders' Equity | 1,207 | 2,857 |
| Total Common Shares Outstanding |